liarozole has been researched along with triazoles in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellens, D; Janssen, PA; Roels, I; Vanden Bossche, H; Willemsens, G | 1 |
| Coogan, MP; Jayne, M; Pautus, S; Simons, C; Yee, SW | 1 |
| Aboraia, AS; Bassett, CE; Brancale, A; Coogan, MP; Pautus, S; Simons, C | 1 |
| Chamcheu, JC; Pavez Loriè, E; Törmä, H; Vahlquist, A | 1 |
1 review(s) available for liarozole and triazoles
| Article | Year |
|---|---|
From 14 alpha-demethylase inhibitors in fungal cells to androgen and oestrogen biosynthesis inhibitors in mammalian cells.
Topics: Androgen Antagonists; Animals; Antifungal Agents; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Estrogen Antagonists; Humans; Imidazoles; Ketoconazole; Oxidoreductases; Sterol 14-Demethylase; Triazoles | 1990 |
3 other study(ies) available for liarozole and triazoles
| Article | Year |
|---|---|
Synthesis and CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]-1H-triazoles.
Topics: Benzofurans; Binding Sites; Cell Line, Tumor; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Activation; Humans; Imidazoles; Ligands; Models, Molecular; Molecular Structure; Protein Conformation; Retinoic Acid 4-Hydroxylase; Stereoisomerism; Structure-Activity Relationship; Tretinoin; Triazoles; Tumor Cells, Cultured | 2006 |
Design and synthesis of substituted imidazole and triazole N-phenylbenzo[d]oxazolamine inhibitors of retinoic acid metabolizing enzyme CYP26.
Topics: Cell Line, Tumor; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; Imidazoles; Ligands; Models, Molecular; Retinoic Acid 4-Hydroxylase; Substrate Specificity; Triazoles | 2009 |
Both all-trans retinoic acid and cytochrome P450 (CYP26) inhibitors affect the expression of vitamin A metabolizing enzymes and retinoid biomarkers in organotypic epidermis.
Topics: Acyltransferases; Alcohol Oxidoreductases; Androgen Antagonists; Benzothiazoles; Biomarkers; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Epidermis; Feedback, Physiological; Gene Expression Regulation, Enzymologic; Heparin-binding EGF-like Growth Factor; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Keratin-2; Keratin-4; Keratinocytes; Receptors, Retinoic Acid; Retinal Dehydrogenase; Retinoic Acid 4-Hydroxylase; Tretinoin; Triazoles; Vitamin A | 2009 |